BlackRock Group’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.25M Buy
64,588
+21,554
+50% +$846K ﹤0.01% 1695
2016
Q3
$1.69M Buy
43,034
+2,389
+6% +$95.3K ﹤0.01% 1733
2016
Q2
$1.54M Sell
40,645
-10,147
-20% -$340K ﹤0.01% 1719
2016
Q1
$1.95M Buy
50,792
+2,839
+6% +$106K ﹤0.01% 1562
2015
Q4
$2.3M Buy
47,953
+9,439
+25% +$437K ﹤0.01% 1401
2015
Q3
$1.52M Buy
38,514
+6,505
+20% +$276K ﹤0.01% 1647
2015
Q2
$1.36M Buy
32,009
+6,644
+26% +$265K ﹤0.01% 1770
2015
Q1
$1M Buy
25,365
+1,348
+6% +$49.7K ﹤0.01% 1865
2014
Q4
$865K Buy
24,017
+6,181
+35% +$208K ﹤0.01% 1967
2014
Q3
$527K Buy
17,836
+760
+4% +$21K ﹤0.01% 2148
2014
Q2
$429K Sell
17,076
-2,947
-15% -$72.9K ﹤0.01% 2259
2014
Q1
$517K Sell
20,023
-3,164
-14% -$79.7K ﹤0.01% 2227
2013
Q4
$522K Sell
23,187
-15,954
-41% -$308K ﹤0.01% 2212
2013
Q3
$556K Buy
39,141
+21,541
+122% +$288K ﹤0.01% 2194
2013
Q2
$240K Buy
+17,600
New +$240K ﹤0.01% 2245

Other funds holding NTUS

BlackRock Group's NTUS Position: Q4 2016 in Review

BlackRock Group increased its Natus Medical Inc (NTUS) stake by 50% in Q4 2016, buying an estimated $846K and bringing the position to 64,588 shares worth $2.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1695.

BlackRock Group first reported a position in NTUS in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.3M in Q4 2015. 237 funds tracked by Wall St. Rank hold NTUS as of Q4 2016.

  • BlackRock Group held 64,588 shares of Natus Medical Inc worth $2.25M as of Q4 2016.
  • BlackRock Group bought 21,554 Natus Medical Inc shares in Q4 2016, an estimated $846K.
  • Natus Medical Inc made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1695 holding.
  • BlackRock Group first reported a position in Natus Medical Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Natus Medical Inc position peaked at $2.3M in Q4 2015.
  • 237 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.